Generate Investment Management Ltd raised its position in Oracle Corporation (NYSE:ORCL – Free Report) by 130.5% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 276,544 shares of the enterprise software provider’s stock after purchasing an additional 156,544 shares during the period. Oracle accounts for approximately 2.0% of Generate Investment Management Ltd’s portfolio, making the stock its 12th biggest holding. Generate Investment Management Ltd’s holdings in Oracle were worth $40,682,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in shares of Oracle by 189.3% in the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after buying an additional 100,494 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after acquiring an additional 404 shares in the last quarter. Sivia Capital Partners LLC grew its stake in Oracle by 21.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 4,348 shares of the enterprise software provider’s stock valued at $951,000 after acquiring an additional 768 shares in the last quarter. United Bank raised its holdings in Oracle by 6.8% in the 2nd quarter. United Bank now owns 15,038 shares of the enterprise software provider’s stock valued at $3,288,000 after acquiring an additional 963 shares during the last quarter. Finally, Schnieders Capital Management LLC. lifted its stake in Oracle by 19.2% in the 2nd quarter. Schnieders Capital Management LLC. now owns 52,856 shares of the enterprise software provider’s stock worth $11,556,000 after purchasing an additional 8,530 shares in the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.
Insider Buying and Selling at Oracle
In related news, EVP Stuart Levey sold 15,000 shares of the stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total value of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares of the company’s stock, valued at $604,155.51. This represents a 81.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company’s stock.
Oracle Stock Performance
Oracle (NYSE:ORCL – Get Free Report) last announced its earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $1.96 by $0.15. The company had revenue of $19.18 billion during the quarter, compared to analysts’ expectations of $19.10 billion. Oracle had a return on equity of 56.43% and a net margin of 25.37%.Oracle’s revenue for the quarter was up 20.6% on a year-over-year basis. During the same period last year, the business posted $1.70 EPS. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, equities research analysts predict that Oracle Corporation will post 6.45 EPS for the current year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 24th. Shareholders of record on Friday, July 10th will be given a $0.50 dividend. The ex-dividend date of this dividend is Friday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.1%. Oracle’s dividend payout ratio is currently 34.31%.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on ORCL shares. Weiss Ratings upgraded Oracle from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, May 29th. Barclays increased their price target on Oracle from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Thursday, June 11th. Oppenheimer lifted their price objective on Oracle from $235.00 to $275.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Piper Sandler boosted their price objective on Oracle from $210.00 to $225.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Finally, Evercore restated an “outperform” rating and issued a $245.00 target price on shares of Oracle in a report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $268.27.
Check Out Our Latest Analysis on ORCL
Key Stories Impacting Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle’s cloud and AI demand story remains strong, with reports highlighting a record backlog/remaining performance obligations that now rival or exceed major tech peers, which supports the long-term revenue outlook. Oracle Has the Biggest Backlog in the AI Industry. Here’s Why the Stock Is Still Down 49%.
- Positive Sentiment: Mizuho reiterated an Outperform rating and a $320 price target, pointing to Oracle’s record fiscal Q4 revenue and ongoing momentum in data center and cloud growth. Mizuho Maintains Outperform Rating on Oracle Corporation (ORCL)
- Positive Sentiment: Baystate Health expanded its strategic collaboration with Oracle Health, expanding the reach of Oracle’s healthcare software and reinforcing commercial adoption of its AI-powered EHR and connected-care tools. Baystate Health and Oracle Health Expand Strategic Collaboration to Create a Connected and Patient-Centered Care Experience
- Neutral Sentiment: Analysts and commentators are discussing Oracle as a potential long-term winner in AI infrastructure, with some bullish forecasts citing the company’s scale and backlog, but these pieces are largely speculative rather than new catalysts. Can Oracle Reach $800 Per Share by 2030? Here’s How It Can Happen
- Neutral Sentiment: Oracle’s workforce reportedly shrank by about 13% in fiscal 2026 as the company continued restructuring and adopting AI across operations, which may improve efficiency but also signals ongoing change. Oracle workforce shrinks by about 13%
- Negative Sentiment: Investors are focused on rising capital expenditures and a planned equity raise, which raised concerns about dilution and weaker free cash flow in the near term. Oracle Stock Tumbles on Higher Capex and Equity Raise – Shorting ORCL Puts Works
- Negative Sentiment: Despite the strong Baystate Health partnership and AI backlog, the stock is still being hit by worries that Oracle’s heavy AI buildout will keep spending elevated before revenue fully catches up. Digging into the Bottlenecks of the AI Build-Out
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Recommended Stories
- Five stocks we like better than Oracle
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
